Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-24-000841
Filing Date
2024-12-13
Accepted
2024-12-13 16:23:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3225
  Complete submission text file 0001971857-24-000841.txt   4669
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-23186 | Film No.: 241548701
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 64 MONTAUK AVENUE STONINGTON CT 06378
Business Address
Hutson Nancy J (Reporting) CIK: 0001379222 (see all company filings)

Type: 144